AZN
Astrazeneca plc
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
AstraZeneca PLC is a leading global biopharmaceutical company based in Cambridge, UK, renowned for its innovative research in the development of prescription medicines across critical therapeutic areas such as oncology, cardiovascular, renal, respiratory, and neuroscience. With a strong and diverse ...
$169.57
-1.19% ($2.04)
Volume
4.67M
52W High
$212.71
52W Low
$68.14
Market Cap
$266.15B
What to Watch This Quarter
Based on historical dataConsensus EPS
$1.27
Whisper EPS
$1.30
2.7% above consensus
Last Quarter
$1.29
Current Streak
4 Beats
Avg Surprise (4Q)
+3.30%
Next Earnings Report
Reports in 13 days
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q1 2026
Apr 29, 2026
1-Day:
+1.17%
5-Day:
-0.94%
Q1 2026
Mar 31, 2026
1-Day:
+1.78%
Q4 2025
Feb 10, 2026
1-Day:
+5.87%
Q3 2025
Nov 6, 2025
1-Day:
+0.97%
5-Day:
+6.35%
Revenue & Financial Performance
Revenue Whisper
$15.36B
TWN Proprietary Estimate
Last Quarter Revenue
$15.29B
+12.5% YoY
Gross Margin
82.5%
Net Margin: 20.2%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q1'26 | $15.29B | +12.5% | 82.5% | 27.8% | $3.08B |
| Q4'25 | $15.50B | +4.1% | 79.9% | 19.2% | $2.33B |
| Q3'25 | $15.19B | +12.0% | 81.6% | 23.6% | $2.53B |
| Q2'25 | $14.46B | +11.7% | 82.9% | 24.3% | $2.45B |
| Q1'25 | $13.59B | +7.2% | 83.5% | 27.0% | $2.92B |
| Q4'24 | $14.89B | +23.8% | 81.7% | 13.7% | $1.50B |
| Q3'24 | $13.57B | +18.0% | 77.3% | 15.5% | $1.43B |
| Q2'24 | $12.94B | +13.3% | 83.1% | 21.2% | $1.93B |
Company Information
Symbol
AZN
Company
Astrazeneca plc
Market Cap
$266.15B
Sector
HEALTHCARE
Next Earnings
Jul 27, 2026
Also Reporting Soon
Companies reporting earnings around the same time as AZN
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - GENERAL
Compare AZN with competitors
Side-by-side earnings comparison